Literature DB >> 15735951

Bipolar radiofrequency-induced thermotherapy (rfitt) for the treatment of spasmodic dysphonia. A report of three cases.

Marc Remacle1, Isabelle Plouin-Gaudon, Georges Lawson, Jean Abitbol.   

Abstract

The symptoms of adductor spasmodic dysphonia are most commonly palliated by periodic botulinum toxin injections. The need for repeated injections, difficulty in obtaining injections and cost make this form of treatment intolerable for some patients. To address these concerns, we propose a new treatment approach utilizing trans-oral recurrent nerve coagulation. The goal is to weaken the force of laryngeal closure during spasms by creating fibrosis of the terminal branches of one recurrent nerve through coagulation. Under general anesthesia without paralysis, an electrical stimulator is used to identify the region within the thyroarytenoid muscle that produces the greatest contraction with minimal stimulation. The radiofrequency laryngeal probe or electrocautery device is introduced into this position, and energy is delivered. The location of the region of maximal stimulation is usually just lateral and anterior to the vocal process of the arytenoids. Between 1989 and 2000, seven patients were treated with electrocautery. To achieve remission of spasms, three patients needed three sessions, four needed two sessions and one only one session. Since 2001, three patients have achieved remission of spasms with a single treatment with radiofrequency during which 80 J was delivered. Voice results are comparable to those obtained with botulinum toxin. Initially, the voice is breathy and laryngeal examination shows complete vocal fold immobility. After 1-2 months, the voice improves and examination reveals unilateral hypomobility. Trans-oral recurrent nerve coagulation is an effective alternative to botulinum toxin injections.

Entities:  

Mesh:

Year:  2005        PMID: 15735951     DOI: 10.1007/s00405-004-0897-7

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  15 in total

1.  Current evidence for the organic etiology of spastic dysphonia.

Authors:  H H Dedo; J J Townsend; K Izdebski
Journal:  Otolaryngology       Date:  1978 Nov-Dec

2.  Recurrent laryngeal nerve pathology in spasmodic dysphonia.

Authors:  J V Bocchino; H M Tucker
Journal:  Laryngoscope       Date:  1978-08       Impact factor: 3.325

3.  Recurrent laryngeal nerve section for spastic dysphonia.

Authors:  H H Dedo
Journal:  Ann Otol Rhinol Laryngol       Date:  1976 Jul-Aug       Impact factor: 1.547

4.  Laryngeal framework surgery in the management of spasmodic dysphonia. Preliminary report.

Authors:  H M Tucker
Journal:  Ann Otol Rhinol Laryngol       Date:  1989-01       Impact factor: 1.547

Review 5.  Surgical management of blepharospasm.

Authors:  R L Anderson; J R Patrinely
Journal:  Adv Neurol       Date:  1988

6.  No morphometric abnormality recurrent laryngeal nerve in spastic dysphonia.

Authors:  J M Ravits; A E Aronson; L W DeSanto; P J Dyck
Journal:  Neurology       Date:  1979-10       Impact factor: 9.910

7.  Partial thyroarytenoid myectomy: an animal study investigating a proposed new treatment for adductor spasmodic dysphonia.

Authors:  S H Genack; P Woo; R H Colton; D Goyette
Journal:  Otolaryngol Head Neck Surg       Date:  1993-03       Impact factor: 3.497

8.  Bilateral thyroarytenoid denervation: a new treatment for laryngeal hyperadduction disorders studied in the canine.

Authors:  J A Sercarz; G S Berke; Y Ming; J Rothschiller; M C Graves
Journal:  Otolaryngol Head Neck Surg       Date:  1992-11       Impact factor: 3.497

9.  Problems with surgical (RLN section) treatment of spastic dysphonia.

Authors:  H H Dedo; K Izdebski
Journal:  Laryngoscope       Date:  1983-03       Impact factor: 3.325

10.  Laryngeal dystonia: a series with botulinum toxin therapy.

Authors:  A Blitzer; M F Brin
Journal:  Ann Otol Rhinol Laryngol       Date:  1991-02       Impact factor: 1.547

View more
  6 in total

Review 1.  [Electrosurgical concepts in ENT medicine. History, fundamentals and practice].

Authors:  G M Bran; M Moch; K Hörmann; B A Stuck
Journal:  HNO       Date:  2007-11       Impact factor: 1.284

2.  Exploration on the underlying mechanism of female predominance in spasmodic dysphonia: an anatomical study of nodose ganglion in rats.

Authors:  Zengrui Xu; Ge Li; Xin Feng
Journal:  Indian J Otolaryngol Head Neck Surg       Date:  2012-09-22

3.  Vocal outcome after endoscopic thyroarytenoid myoneurectomy in patients with adductor spasmodic dysphonia.

Authors:  Sachin Gandhi; Marc Remacle; Prasun Mishra; Vrushali Desai
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-06-12       Impact factor: 2.503

4.  Current and future medical treatment in primary dystonia.

Authors:  Cathérine C S Delnooz; Bart P C van de Warrenburg
Journal:  Ther Adv Neurol Disord       Date:  2012-07       Impact factor: 6.570

5.  Radiofrequency transoral microsurgical procedures in benign and malignant laryngeal and hypopharyngeal lesions (institutional experiences).

Authors:  Krisztina Somogyvári; Imre Gerlinger; László Lujber; András Burián; Péter Móricz
Journal:  ScientificWorldJournal       Date:  2015-02-18

Review 6.  Treatment for spasmodic dysphonia: limitations of current approaches.

Authors:  Christy L Ludlow
Journal:  Curr Opin Otolaryngol Head Neck Surg       Date:  2009-06       Impact factor: 1.814

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.